Our assessment
MyDrHank prices three preparations per month with no plan commitment attached, and it cites the two pivotal trials by author and journal beside its efficacy claims — including the sentence admitting those trials used the FDA-approved formulations rather than the compounded ones it sells. That is more care with evidence than most of this category takes. It is also the only seller here whose terms say outright that the list of pharmacy partners is available on request, which is a refusal rather than an oversight.
A from-rate with nothing above it
Each product card prints a from-rate per month, and the button beside it says there is no commitment. There is no plan ladder anywhere on the site: no quarterly rung, no six-month rung, no annual prepayment.
So the figure isn't a prepaid total wearing a monthly label, which is the usual trick elsewhere in this comparison. It is a floor. No dose ladder is published above it, so what a maintenance dose costs stays undisclosed.
One product page offers a second formulation as a tab. Select it and the figure doesn't change, and no separate price appears for it.
The pharmacy list is withheld, in writing
The terms of use state that pharmacy partners are licensed pharmacies operating in the United States, and that a current list is available upon request.
That is a different thing from silence. Most sellers here simply never mention the pharmacy. This one has considered the question and decided not to answer it on the page.
Careful with the trial data, quiet about the clinicians
The efficacy claims carry footnotes naming the trial, the lead author, the journal, the year, the cohort size and the duration. Each footnote says the data reflects FDA-approved formulations while the medication dispensed is compounded and not FDA-approved.
The same care doesn't extend to the clinical team. No medical director and no prescribing clinician is named anywhere. The terms say providers are licensed in the states where they treat, and name no states.
MyDrHank's published pricing
Prices re-verified September 2026
| Medication | Price |
|---|---|
| MedicationSemaglutide (compounded) — semaglutide with B-12, once-weekly injection, starting rate | Price$178/mostarting price, per month, no commitment required — the seller publishes no plan ladder, prepayment option or dose ladder above this floor rate |
| MedicationTirzepatide (compounded) — tirzepatide with B-12, once-weekly injection, starting rate | Price$240/mostarting price, per month — the seller publishes no plan ladder or dose ladder above this floor rate |
| MedicationSemaglutide (compounded-oral) — daily tablet, starting rate | Price$171/mostarting price, per month, for the oral option — the seller publishes no plan ladder or dose ladder above this floor rate |
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
See MyDrHank's current price →Who MyDrHank suits
Good fit if
- Readers who want a starting monthly rate with no plan commitment behind it.
- Buyers who want efficacy claims sourced to a named trial rather than asserted.
- People who want a needle-free daily tablet priced beside the injections.
Look elsewhere if
- Anyone who needs the dispensing pharmacy named on the page.
- Readers who want a prescribing clinician or medical director they can look up.
- Buyers who need to know their state is served, or what a higher dose will cost.
What stands out about MyDrHank
Strengths
- Publishes a starting monthly rate for three separate preparations without hiding a prepayment behind any of them
- States that there is no commitment beside the price, so the figure is not a prepaid rate wearing a monthly label
- Cites the two pivotal trials by name, author and journal beside its efficacy claims, and says outright that those trials used the FDA-approved formulations rather than the compounded ones it sells
- Offers a needle-free daily tablet at a published rate alongside the injections
Trade-offs
- Its terms state that the list of pharmacy partners is available only on request, which is a refusal to publish rather than an omission
- Names no individual prescribing clinician or medical director anywhere on the site
- Publishes no list of states it serves; its terms say only that providers are licensed in the states where they treat
- Every price is a starting figure with no dose ladder above it, so what a higher dose costs is not published
- Compounded medications are not FDA-approved finished drug products
How this review was verified
- No page on the site carries a plan ladder or a prepayment option, so each figure is a starting monthly rate rather than a divided total.
- The alternative formulation on one product page is a tab with no separate price attached.
- The terms of use state that the pharmacy partner list is available on request, and name no states.
- Each efficacy footnote names its trial and says the data reflects FDA-approved formulations while the medication dispensed is compounded.
Where MyDrHank ranks
MyDrHank qualifies for 4 of the 6 boards on this site. A board only ranks the providers that meet its own condition, so a missing board means MyDrHank does not publish what that board sorts on.
- Semaglutide — #22 of 334
- Tirzepatide — #20 of 319
- Cheapest Overall — #23 of 396
- Oral — #7 of 108
Compare MyDrHank directly
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
| Provider | Score | From/mo | Full review | Action |
|---|---|---|---|---|
| Belle Health | 10.0/10 | From/mo$109Advertised monthly equivalent for a twelve-month supply; not a verified monthly installment. Six-month rate $119, two-month rate $135, one-month rate $199. Confirm the upfront payment and refill schedule. | Full reviewRead the Belle Health review | Visit |
| Midi Health | 10.0/10 | From/mo$164for a 4-week supply, the lowest of four published dose tiers, including shipping | Full reviewRead the Midi Health review | Visit |
| altRx | 8.6/10 | From/mo$89/moadvertised monthly starting price for a multi-dose vial; confirm plan length and checkout total | Full reviewRead the altRx review | Visit |
Frequently asked questions
Is the advertised figure a monthly rate?
Yes, and it is a starting rate. It isn't a prepaid total divided: no plan ladder of any length exists anywhere on the site, and the button states there is no commitment.
Which pharmacy fills the prescription?
Not published. The terms state that a current list of pharmacy partners is available on request.
Is a prescribing clinician named?
No. No medical director or individual prescriber appears anywhere on the site.
Which states does it serve?
Not published. The terms say only that providers are licensed in the states where they treat patients, and that the service is available in the United States.
What does a higher dose cost?
Not published. Each price is a starting figure and no dose ladder appears above it.
Ready to compare directly?
MyDrHank scores 2.9/10 on this site's rubric. Review the published prices and their conditions above, then confirm your total with the provider. Visiting its site does not commit you to treatment.
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
Visit MyDrHank →